Epocrates Inc. Files for $75 Million IPO
Published: Jul 19, 2010
J.P. Morgan Securities Inc. and Piper Jaffray & Co. are serving as joint book-running managers for the proposed offering. William Blair & Company, L.L.C. and JMP Securities LLC are acting as co-managers. The number of shares to be sold and the price range for the proposed offering have not yet been determined.
A registration statement relating to Epocrates' securities has been filed with the Securities and Exchange Commission, but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time that the registration statement becomes effective. This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
The proposed offering will be made only by means of a prospectus. Once the prospectus is available, a copy may be obtained from J.P. Morgan Securities Inc., c/o Broadridge Financial Solutions, 1155 Long Island Ave, Edgewood, NY, 11717, or by calling 1-866-803-9204, or from Piper Jaffray & Co., 800 Nicollet Mall, Suite 800, Minneapolis, MN 55402, or by calling 1-800-747-3924 or sending an email to firstname.lastname@example.org.
Epocrates is a leading provider of mobile drug reference tools and interactive services to healthcare professionals and the healthcare industry. Epocrates' active user network currently has more than one million healthcare professionals, including more than 40 percent of U.S. physicians. Most commonly used on mobile devices at the point of care, the company's products and services help healthcare professionals make more informed prescribing decisions, enhance patient safety and improve practice productivity.
SOURCE: Epocrates, Inc.
Investor and Press Contact Epocrates, Inc. Erica Sniad Morgenstern, 650-227-6907 email@example.com
Copyright Business Wire 2010